Waiting Guest Post by Robert Hanlon I’m waiting for results. Or rather, I’m not waiting. I’m trying to be not waiting. Most of the time it works. I’ve talked about, written about strolling toward death. Where I do not think about it, and mosey on my way since there is nothing to be done, and [...]
Strolling Towards Death Guest Post By Robert Hanlon I’m dying. Yes, yes, we’re all dying, from the moment of birth, blah, blah, blah. But me, a little more so. My cancer is back. I’m not sick. I have an illness, if that’s what prostate cancer is. Or a disease. Or a condition. I’ve periodically read [...]
Paranoia, anger, fear, and acting out fantasies of a violent nature from men on Prostate Cancer androgen deprivation therapy are some of the reports we've received over the last year. Obviously, these are concerning and under-reported by the medical community. We have heard from people in our support groups, but have not heard or read [...]
https://vimeo.com/220740406#t=22s
We're wondering if anyone is using Jevtana as a treatment for advanced stage prostate cancer. We're wondering what Jevtana's quality of life impact is on patients. Please email me at info@malecare.org if you are using it .... do tell us what your Jevtana experience is like.
Breakthroughs in Prostate Cancer https://vimeo.com/220740406 An interesting discussion about prostate cancer breakthroughs, some of which patients can use today, with: Philip Kantoff, MD, Chair, Department of Medicine, Memorial Sloan Kettering Cancer Center Daniel Petrylak, MD, Director, Genitourinary Oncology, Co-Director, Signal Transduction Research Program, Yale University Cancer Center Sumit Subudhi, MD, Assistant Professor, Department of Genitourinary [...]
A new study from Italy showed that using statins while on Xtandi would help extend life longer than without using the statins. The study compared the use of statins in men taking Xtandi and men taking Zytiga. While statins helped men who were taking Xtandi, taking statins was of no help to men taking Zytiga. [...]
A breast cancer test may be adapted to help men with advanced stage prostate cancer know – in advance - if androgen deprivation therapy (ADT) will help them. Researchers from UCSF and the University of Michigan investigated genetic subtypes of prostate cancer, to see what the difference could predict. The researchers divided prostate tumors into [...]
As we get ready for next weeks' American Society of Clinical Oncology annual meeting, I thought advanced prostate cancer patients would find it helpful to see this thirty minute review from last years meeting. Click >>> https://www.patientpower.info/video/asco-advanced-prostate-cancer-roundtable-discussion http://malecare.org/the-development-of-a-novel-blood-biomarker-for-detecting-ar-v7-and-resistance-to-zytiga-and-xtandi/
Androgen deprivation therapy (ADT) is a first line treatment for men when prostate cancer has spread beyond the prostate. Men die from prostate cancer after their disease becomes castration resistant prostate cancer (CRPC). Anti-androgen treatments such as Enzalutamide (Xtandi) have lengthened the life of thousands of advanced prostate cancer men around the world. Ultimately, even [...]
